{"id":"W3082666946","doi":"10.2217/fon-2020-0521","title":"Belantamab Mafodotin in the Treatment of Relapsed or Refractory Multiple Myeloma","year":2020,"lang":"en","type":"review","venue":"Future Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Janssen Biotech; Celgene; Genentech; Amgen","keywords":"Medicine; Multiple myeloma; Refractory (planetary science); Clinical trial; Oncology; Internal medicine; Antigen; Population; Chimeric antigen receptor; Antibody; Antibody-drug conjugate; Drug; Immunology; Immunotherapy; Cancer research; Cancer; Pharmacology; Monoclonal antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002266674,0.0005612471,0.003227188,0.0003036327,0.00006170027,0.000008924915,0.0003400524,0.0008031306,0.0003999658],"category_scores_gemma":[0.0002470016,0.0002609424,0.0006580686,0.0005979568,0.0001299127,0.00002782996,0.00005060642,0.000721372,0.0002396005],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001186391,"about_ca_system_score_gemma":0.001794567,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001167297,"about_ca_topic_score_gemma":0.0006762699,"domain_scores_codex":[0.9966696,0.0009416266,0.0008661803,0.0005867577,0.0004098132,0.0005260578],"domain_scores_gemma":[0.9969937,0.001557896,0.0004318923,0.000723991,0.00005910254,0.0002333865],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001648923,0.002549925,0.0002420241,0.003857496,0.0007049023,0.007901546,0.000763528,1.973489e-8,0.000002215627,0.00002464947,0.002319649,0.9799851],"study_design_scores_gemma":[0.007273149,0.01164994,0.0008651033,0.001675644,0.001097912,0.0008417119,0.0003117422,0.000003881833,0.000003357674,0.000002481605,0.9760965,0.000178621],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002365565,0.9914352,9.380959e-7,0.001095418,0.0003926548,0.003585124,0.0002119608,0.00003576753,0.003006344],"genre_scores_gemma":[0.0002284605,0.9949774,0.0006353608,0.0001346127,0.001309377,0.0007419532,0.0008637691,0.00006948122,0.00103958],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9798065,"threshold_uncertainty_score":0.9999843,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08867892424622806,"score_gpt":0.4105295756180951,"score_spread":0.3218506513718671,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}